宏柏新材(605366) - 2024 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2024 was ¥332,554,714.36, a decrease of 9.07% compared to the same period last year[2]. - The net profit attributable to shareholders for Q3 2024 was -¥24,903,627.00, representing a decline of 211.79% year-over-year[2]. - The net profit attributable to shareholders after deducting non-recurring gains and losses for Q3 2024 was -¥28,278,697.89, a decrease of 501.79% compared to the previous year[2]. - The basic earnings per share for Q3 2024 was -¥0.04, a decline of 200.00% year-over-year[3]. - The diluted earnings per share for Q3 2024 was -¥0.02, a decrease of 150.00% compared to the same period last year[3]. - The net profit attributable to shareholders for the year-to-date period was -¥14,061,868.79, a decline of 127.27% compared to the same period last year[2]. - Net profit for the third quarter of 2024 was CNY -14,061,868.79, compared to a net profit of CNY 51,559,762.29 in the same quarter of 2023, indicating a significant decline[18][19]. - The net profit for the first three quarters of 2024 was a loss of CNY 23,070,693.70, compared to a profit of CNY 3,215,469.97 in the same period of 2023[28]. Assets and Liabilities - The total assets at the end of Q3 2024 were ¥4,070,977,411.79, an increase of 35.72% from the end of the previous year[3]. - The company's total current assets amount to approximately RMB 2.13 billion, an increase from RMB 1.04 billion in the previous period[14]. - The total assets of the company are reported at approximately RMB 4.07 billion, up from RMB 3.00 billion in the previous period[14]. - The company's total liabilities increased to CNY 1,996,414,836.69, up from CNY 1,010,920,068.06 in the previous year[16]. - The total equity attributable to shareholders reached CNY 2,074,562,575.10, an increase from CNY 1,988,713,479.46 year-over-year[16]. - The company's total liabilities decreased to ¥1,200,000,000.00 from ¥1,500,000,000.00, indicating a reduction of 20%[24]. - The total assets increased to CNY 4,126,702,324.97, up from CNY 3,036,423,996.16 in the previous year, reflecting a growth of 36%[26]. - The total liabilities rose to CNY 2,138,897,231.58, compared to CNY 1,124,895,286.06 in the previous year, indicating an increase of 90%[26]. Cash Flow - The cash flow from operating activities for the year-to-date period increased by 95.43% to ¥288,168,150.05[7]. - The company reported a significant increase in cash flow due to higher sales receipts and reduced cash payments for goods and services compared to the previous year[7]. - Total cash inflow from operating activities for the first three quarters of 2024 reached ¥978,119,020.24, an increase from ¥941,809,641.42 in the same period of 2023, representing a growth of approximately 3.3%[21]. - Net cash flow from operating activities increased significantly to ¥288,168,150.05, compared to ¥147,456,651.18 in the previous year, marking an increase of about 95.5%[22]. - Cash inflow from investment activities totaled ¥184,164,859.76, up from ¥66,804,677.40 in the same period last year, indicating a substantial increase of approximately 176.5%[22]. - Cash inflows from financing activities reached CNY 1,363,928,129.78 in 2024, a substantial increase from CNY 510,144,860.00 in 2023, representing a growth of 167.5%[29]. - The net cash flow from financing activities was CNY 997,815,621.34 in 2024, compared to CNY 135,868,974.84 in 2023, showing an increase of 634.5%[29]. Shareholder Information - The total number of common shareholders at the end of the reporting period is 27,089[9]. - The largest shareholder, Hongbo Chemical Co., Ltd., holds 137,646,667 shares, accounting for 22.61% of the total shares[11]. - The company has reported a total of 6.16% shares held by individual shareholder Wu Hua[11]. Research and Development - Research and development expenses for the first three quarters were CNY 30,484,571.43, up from CNY 26,609,797.87 in the same period last year, reflecting a focus on innovation[17]. - Research and development expenses for the first three quarters of 2024 were CNY 30,021,299.12, up from CNY 26,437,052.58 in the same period of 2023, marking a growth of 10.0%[27]. Financial Strategy and Future Outlook - The company plans to enhance market expansion strategies and product development to recover from the current financial downturn[18]. - The company's cash flow from operating activities remains a critical area for future improvement, as indicated by the net loss reported[18].